Abstract: A wrench comprises a handle, a tube, an actuating-part and a scale mark area; the handle comprises a hollow rotation handle, a movable plug, a screw rod drive component and a locking component, an end of the hollow rotation handle engages with a tail end portion of the scale mark area by rotation, the screw rod drive component comprises a rotary portion and a screw rod portion, and an adjusting threaded-sleeve is sleeved over the screw rod portion; a tube positioning piece engaging with the rotary portion by rotation is provided on the rotary portion; the locking component comprises a handle insert and positioning pins, the handle insert is installed on the rotary portion via a key and an outer surface of the handle insert is connected with an inner surface of the hollow rotation handle, and positioning pins are provided at a front end portion of the movable plug.

Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.

Abstract: A ligand-drug conjugate and the use of the ligand-drug conjugate.

Abstract: A wrench comprises a handle, a tube, an actuating-part and a scale mark area; the handle comprises a hollow rotation handle, a movable plug, a screw rod drive component and a locking component, an end of the hollow rotation handle engages with a tail end portion of the scale mark area by rotation, the screw rod drive component comprises a rotary portion and a screw rod portion, and an adjusting threaded-sleeve is sleeved over the screw rod portion; a tube positioning piece engaging with the rotary portion by rotation is provided on the rotary portion; the locking component comprises a handle insert and positioning pins, the handle insert is installed on the rotary portion via a key and an outer surface of the handle insert is connected with an inner surface of the hollow rotation handle, and positioning pins are provided at a front end portion of the movable plug.

Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.

Abstract: A wrench comprises a handle, a tube, an actuating-part and a scale mark area; the handle comprises a hollow rotation handle, a movable plug, a screw rod drive component and a locking component, an end of the hollow rotation handle engages with a tail end portion of the scale mark area by rotation, the screw rod drive component comprises a rotary portion and a screw rod portion, and an adjusting threaded-sleeve is sleeved over the screw rod portion; a tube positioning piece engaging with the rotary portion by rotation is provided on the rotary portion; the locking component comprises a handle insert and positioning pins, the handle insert is installed on the rotary portion via a key and an outer surface of the handle insert is connected with an inner surface of the hollow rotation handle, and positioning pins are provided at a front end portion of the movable plug.

Abstract: An anti-lock brake apparatus, a vehicle, an electric vehicle and an electric-assisted vehicle. The anti-lock brake apparatus is applied to a brake system, and the brake system is used to provide a brake frictional force for a wheel, the brake system includes a brake oil pipeline, and the anti-lock brake apparatus includes: a volume-adjusting part, the volume-adjusting part has a volume chamber, the volume chamber is connected into the brake oil pipeline, a volume of the volume chamber is continuously adjustable, the volume-adjusting part adjusts the volume of the volume chamber according to a state parameter of the wheel, to enable an oil pressure in the brake oil pipeline to vary, and the brake frictional force exerted on the wheel by the brake system is adjustable. The apparatus has high reliability and high brake efficiency.

Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.

Abstract: The present disclosure discloses a conjugate compound or a pharmaceutically acceptable salt thereof, comprising a payload and two targeting molecules. Further disclosed herein is a pharmaceutical composition, comprising the conjugate compound or the pharmaceutically acceptable salt thereof. The present disclosure additionally relates to a method for delivering a payload to a subject in need thereof, and a method for treating a disease, wherein the methods comprise administering to the subject a therapeutically effective amount of the conjugate compound or the pharmaceutically acceptable salt thereof, or the pharmaceutical composition as disclosed herein.

Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.

Abstract: A perovskite solar module and a preparation method thereof. The perovskite solar module includes: a substrate; a transparent conductive oxide layer provided on at least a part of a surface of the substrate; an electron transport layer provided on at least a part of a surface of the transparent conductive oxide layer facing away from the substrate; a photoactive layer provided on at least a part of a surface of the electron transport layer facing away from the transparent conductive oxide layer; a hole transport layer provided on at least a part of a surface of the photoactive layer facing away from the electron transport layer; an electrode provided on at least a part of a surface of hole transport layer facing away from the photoactive layer; and a barrier layer provided in the photoactive layer and separating the photoactive layer apart from a protrusion of the electrode.

Abstract: A compact and miniaturized Fourier transform photoluminescence (PL) spectrometer is provided comprising five functional modules, which are all mounted on a same baseplate: (i) a sample placement module for positioning and spatially adjusting the sample to be tested, which includes a 3-axis stage (10) and a position mark (11) for the expected front surface of the sample being tested. The stage is employed for positioning the sample directly or a low-temperature optical cryostat that contains the sample (said sample and cryostat being not parts of the spectrometer), the position mark indicates the pre-aligned position for the projection of the sample's front surface in the horizontal plane; (ii) a built-in pump light source module for generating PL signal, which includes two lasers (20) and (21) with different laser wavelengths, the lasers' output can be selected on request in the wavelength range from ultraviolet to near-infrared.

Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Abstract: A compact and miniaturized Fourier transform photoluminescence (PL) spectrometer is provided comprising five functional modules, which are all mounted on a same baseplate: (i) a sample placement module for positioning and spatially adjusting the sample to be tested, which includes a 3-axis stage (10) and a position mark (11) for the expected front surface of the sample being tested. The stage is employed for positioning the sample directly or a low-temperature optical cryostat that contains the sample (said sample and cryostat being not parts of the spectrometer.), the position mark indicates the pre-aligned position for the projection of the sample's front surface in the horizontal plane; (ii) a built-in pump light source module for generating PL signal, which includes two lasers (20) and (21) with different laser wavelengths, the lasers' output can be selected on request in the wavelength range from ultraviolet to near-infrared.

Abstract: The present disclosure provides, inter alia, pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. In certain embodiments, the pharmaceutical compositions contain nonabsorbable pharmaceutical composition and may be used, for example, to treat eubicarbonatemic metabolic acidosis.

Abstract: The present invention provides crosslinked amine polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritus, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.

Abstract: The present invention provides a crosslinked amine and amide polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritis, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.